Alladapt Immunotherapeutics

When this West-Coast based biotech sought to establish manufacturing operations in Pennsylvania, they turned to Genesis. We worked closely with our client to determine how to best utilize their 53,125 SF space, which was allocated for Phase III clinical trials and subsequent commercial production.

The client contracted us to design and construct 12,000 SF of space for cGMP manufacturing and the remaining 38,000 SF for warehouse and support areas. The manufacturing operations, contracted to a local CMO, will produce products for Europe and the United States so the facility must meet regulatory compliance for those markets. The facility is currently under construction with an anticipated completion date of December 2023.